Alternative investment manager Stafford Capital Partners has raised $484 million for its Stafford International Timberland VII Fund, exceeding its $400 million target with support from investors in the U.K., Europe and Australia.
SIT VII, Stafford’s seventh fund, pharmacy is a specialist timberland fund of funds acquiring secondary positions in existing timberland funds as well as investing in primary timberland funds and co-investments.

“We are very pleased with the support we continue to receive from existing investors and grateful for the confidence new investors have given us, seek ” Stafford CEO Angus Wheatley said in a statement. “To assist in the investment of this latest fund, we have increased our investment team with the addition of two investment managers and a further analyst to support the finance function, as well as plans to open an office in Latin America in the third quarter of this year.”

SIT VII has already made two secondary investments, one co-investment and a primary commitment, all with leading timberland investment managers. Along with a further co-investment and primary commitment made recently, the firm said SIT VII will have invested nearly 21 percent of committed capital.

Timberland funds mainly invest in tree farms and managed natural forests, profiting from biological growth, land price appreciation and other factors. Stafford’s Timberland units manages investments in the U.S., Canada, Brazil, Uruguay, Chile, Central America, New Zealand and Australia, according to its website.